Deferred Tax Assets, Valuation Allowance of Caris Life Sciences, Inc. from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Caris Life Sciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
  • Caris Life Sciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $410,409,000, a 2.6% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Caris Life Sciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $410,409,000 -$11,169,000 -2.6% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q4 2024 $421,578,000 31 Dec 2024 10-K 03 Mar 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.